Home › Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca
 

Keywords :   


Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca

2014-01-03 11:53:31| Biotech - Topix.net

Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca .

Tags: program transfers inhibitor astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Tropical Storm Joyce Graphics
29.09Tropical Storm Joyce Forecast Advisory Number 9
29.09Summary for Tropical Storm Joyce (AT1/AL112024)
29.09Hurricane Isaac Graphics
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Oasis ticket seller and promoter bosses get 14.8m
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
More »